Vanguard Fiduciary Trust’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.98M Sell
775,085
-47,884
-6% -$175K ﹤0.01% 2461
2026
Q1
$3.25M Buy
+822,969
New +$4.15M ﹤0.01% 2317

Other funds holding MDXG

Vanguard Fiduciary Trust's MDXG Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its MiMedx Group (MDXG) stake by 5.8% in Q2 2026, selling an estimated $175K and leaving 775,085 shares worth $2.98M. The position accounts for ﹤0.01% of the portfolio, ranked #2461.

Vanguard Fiduciary Trust first reported a position in MDXG in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.25M in Q1 2026. 225 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Vanguard Fiduciary Trust held 775,085 shares of MiMedx Group worth $2.98M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 47,884 MiMedx Group shares in Q2 2026, an estimated $175K.
  • MiMedx Group made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2461 holding.
  • Vanguard Fiduciary Trust first reported a position in MiMedx Group in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's MiMedx Group position peaked at $3.25M in Q1 2026.
  • 225 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.